Skip to main content
. 2010 Oct 26;25(11):1601–1608. doi: 10.3346/jkms.2010.25.11.1601

Fig. 4.

Fig. 4

Kaplan-Meier analysis of primary endpoint of UFH and LMWH groups with glycoprotein IIb/IIIa inhibitor (A) and without glycoprotein IIb/IIIa inhibitor (B) in STEMI patients who underwent primary PCI.

LMWH, low molecular weight heparin; UFH, unfractionated heparin; STEMI, ST-elevation myocardial infarction; PCI, percutaneous coronary intervention.